Open AccessResidual Risk of Cardiovascular Complications in Case of Adequate Lipid-Lowering Therapy
Author(s) -
В В Симерзин,
В В Симерзин,
О В Фатенков,
О В Фатенков,
И В Гаглоева,
И В Гаглоева,
М А Галкина,
М А Галкина,
YaA A Panisheva,
Я А Панишева
Publication year - 2018
Publication title -
nauka i innovacii v medicine
Language(s) - English
Resource type - Journals
eISSN - 2618-754X
pISSN - 2500-1388
DOI - 10.35693/2500-1388-2018-0-2-19-25
Subject(s) - residual risk , pharmacotherapy , residual , risk factor , medicine , computer science , algorithm
This article is devoted to the problems of residual risk of cardiovascu1ar comp1ications deve1opment for high and very high risk patients under adequate lipid-fowering pharmacotherapy in spite of c^lestera! and tow-density 1ipoproteins target level achievement. Afong with classic risk factors the special atte^ton is given to 1ipoprotein (a) [LP (a)] as the most aggressive factor of cardwvascular system atherosclerotic diseases devetopment and their comp1ications. Great importance is attached to 1ipidopheresis.